Global Anti-Obesity Drugs Market Research Report 2018

2018-12-07 / 2900.00 / Pharma & Healthcare / 120 Pages

Description

This report studies the global Anti-Obesity Drugs market status and forecast, categorizes the global Anti-Obesity Drugs market size (value & volume) by manufacturers, type, application, and region. This report focuses on the top manufacturers in North America, Europe, Japan, China, and other regions (India, Southeast Asia).

The major manufacturers covered in this report
Pfizer
Merck
F.Hoffmann-La Roche
GlaxoSmithKline
AstraZeneca
Boehringer Ingelheim
Novo Nordisk
Eisai
Norgine
Arena Pharmaceuticals
Orexigen Therapeutics
Vivus
Alizyme
Rhythm Pharmaceuticals
Shionogi
Zafgan

Geographically, this report studies the top producers and consumers, focuses on product capacity, production, value, consumption, market share and growth opportunity in these key regions, covering
North America
Europe
China
Japan
Southeast Asia
India

We can also provide the customized separate regional or country-level reports, for the following regions:
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Rest of Asia-Pacific
Europe
Germany
France
UK
Italy
Spain
Russia
Rest of Europe
Central & South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Saudi Arabia
Turkey
Rest of Middle East & Africa

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
Prescription Drugs
OTC drugs
On the basis of the end users/applications, this report focuses on the status and outlook for major applications/end users, consumption (sales), market share and growth rate for each application, including
6-18 Callant
18-30 Adult
30-60Middle-Aged
Others

The study objectives of this report are:
To analyze and study the global Anti-Obesity Drugs capacity, production, value, consumption, status (2013-2017) and forecast (2018-2025);
Focuses on the key Anti-Obesity Drugs manufacturers, to study the capacity, production, value, market share and development plans in future.
Focuses on the global key manufacturers, to define, describe and analyze the market competition landscape, SWOT analysis.
To define, describe and forecast the market by type, application and region.
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends and factors driving or inhibiting the market growth.
To analyze the opportunities in the market for stakeholders by identifying the high growth segments.
To strategically analyze each submarket with respect to individual growth trend and their contribution to the market
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market
To strategically profile the key players and comprehensively analyze their growth strategies.

In this study, the years considered to estimate the market size of Anti-Obesity Drugs are as follows:
History Year: 2013-2017
Base Year: 2017
Estimated Year: 2018
Forecast Year 2018 to 2025

For the data information by region, company, type and application, 2017 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Key Stakeholders
Anti-Obesity Drugs Manufacturers
Anti-Obesity Drugs Distributors/Traders/Wholesalers
Anti-Obesity Drugs Subcomponent Manufacturers
Industry Association
Downstream Vendors

Available Customizations
With the given market data, QYResearch offers customizations according to the company's specific needs. The following customization options are available for the report:
Regional and country-level analysis of the Anti-Obesity Drugs market, by end-use.
Detailed analysis and profiles of additional market players.

Table of Content

Table of Contents

Global Anti-Obesity Drugs Market Research Report 2018
1 Anti-Obesity Drugs Market Overview
1.1 Product Overview and Scope of Anti-Obesity Drugs
1.2 Anti-Obesity Drugs Segment by Type (Product Category)
1.2.1 Global Anti-Obesity Drugs Production and CAGR (%) Comparison by Type (Product Category)(2013-2025)
1.2.2 Global Anti-Obesity Drugs Production Market Share by Type (Product Category) in 2017
1.2.3 Prescription Drugs
1.2.3 OTC drugs
1.3 Global Anti-Obesity Drugs Segment by Application
1.3.1 Anti-Obesity Drugs Consumption (Sales) Comparison by Application (2013-2025)
1.3.2 6-18 Callant
1.3.3 18-30 Adult
1.3.4 30-60Middle-Aged
1.3.5 Others
1.4 Global Anti-Obesity Drugs Market by Region (2013-2025)
1.4.1 Global Anti-Obesity Drugs Market Size (Value) and CAGR (%) Comparison by Region (2013-2025)
1.4.2 North America Status and Prospect (2013-2025)
1.4.3 Europe Status and Prospect (2013-2025)
1.4.4 China Status and Prospect (2013-2025)
1.4.5 Japan Status and Prospect (2013-2025)
1.4.6 Southeast Asia Status and Prospect (2013-2025)
1.4.7 India Status and Prospect (2013-2025)
1.5 Global Market Size (Value) of Anti-Obesity Drugs (2013-2025)
1.5.1 Global Anti-Obesity Drugs Revenue Status and Outlook (2013-2025)
1.5.2 Global Anti-Obesity Drugs Capacity, Production Status and Outlook (2013-2025)

2 Global Anti-Obesity Drugs Market Competition by Manufacturers
2.1 Global Anti-Obesity Drugs Capacity, Production and Share by Manufacturers (2013-2018)
2.1.1 Global Anti-Obesity Drugs Capacity and Share by Manufacturers (2013-2018)
2.1.2 Global Anti-Obesity Drugs Production and Share by Manufacturers (2013-2018)
2.2 Global Anti-Obesity Drugs Revenue and Share by Manufacturers (2013-2018)
2.3 Global Anti-Obesity Drugs Average Price by Manufacturers (2013-2018)
2.4 Manufacturers Anti-Obesity Drugs Manufacturing Base Distribution, Sales Area and Product Type
2.5 Anti-Obesity Drugs Market Competitive Situation and Trends
2.5.1 Anti-Obesity Drugs Market Concentration Rate
2.5.2 Anti-Obesity Drugs Market Share of Top 3 and Top 5 Manufacturers
2.5.3 Mergers & Acquisitions, Expansion

3 Global Anti-Obesity Drugs Capacity, Production, Revenue (Value) by Region (2013-2018)
3.1 Global Anti-Obesity Drugs Capacity and Market Share by Region (2013-2018)
3.2 Global Anti-Obesity Drugs Production and Market Share by Region (2013-2018)
3.3 Global Anti-Obesity Drugs Revenue (Value) and Market Share by Region (2013-2018)
3.4 Global Anti-Obesity Drugs Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
3.5 North America Anti-Obesity Drugs Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
3.6 Europe Anti-Obesity Drugs Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
3.7 China Anti-Obesity Drugs Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
3.8 Japan Anti-Obesity Drugs Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
3.9 Southeast Asia Anti-Obesity Drugs Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
3.10 India Anti-Obesity Drugs Capacity, Production, Revenue, Price and Gross Margin (2013-2018)

4 Global Anti-Obesity Drugs Supply (Production), Consumption, Export, Import by Region (2013-2018)
4.1 Global Anti-Obesity Drugs Consumption by Region (2013-2018)
4.2 North America Anti-Obesity Drugs Production, Consumption, Export, Import (2013-2018)
4.3 Europe Anti-Obesity Drugs Production, Consumption, Export, Import (2013-2018)
4.4 China Anti-Obesity Drugs Production, Consumption, Export, Import (2013-2018)
4.5 Japan Anti-Obesity Drugs Production, Consumption, Export, Import (2013-2018)
4.6 Southeast Asia Anti-Obesity Drugs Production, Consumption, Export, Import (2013-2018)
4.7 India Anti-Obesity Drugs Production, Consumption, Export, Import (2013-2018)

5 Global Anti-Obesity Drugs Production, Revenue (Value), Price Trend by Type
5.1 Global Anti-Obesity Drugs Production and Market Share by Type (2013-2018)
5.2 Global Anti-Obesity Drugs Revenue and Market Share by Type (2013-2018)
5.3 Global Anti-Obesity Drugs Price by Type (2013-2018)
5.4 Global Anti-Obesity Drugs Production Growth by Type (2013-2018)

6 Global Anti-Obesity Drugs Market Analysis by Application
6.1 Global Anti-Obesity Drugs Consumption and Market Share by Application (2013-2018)
6.2 Global Anti-Obesity Drugs Consumption Growth Rate by Application (2013-2018)
6.3 Market Drivers and Opportunities
6.3.1 Potential Applications
6.3.2 Emerging Markets/Countries

7 Global Anti-Obesity Drugs Manufacturers Profiles/Analysis
7.1 Pfizer
7.1.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.1.2 Anti-Obesity Drugs Product Category, Application and Specification
7.1.2.1 Product A
7.1.2.2 Product B
7.1.3 Pfizer Anti-Obesity Drugs Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
7.1.4 Main Business/Business Overview
7.2 Merck
7.2.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.2.2 Anti-Obesity Drugs Product Category, Application and Specification
7.2.2.1 Product A
7.2.2.2 Product B
7.2.3 Merck Anti-Obesity Drugs Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
7.2.4 Main Business/Business Overview
7.3 F.Hoffmann-La Roche
7.3.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.3.2 Anti-Obesity Drugs Product Category, Application and Specification
7.3.2.1 Product A
7.3.2.2 Product B
7.3.3 F.Hoffmann-La Roche Anti-Obesity Drugs Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
7.3.4 Main Business/Business Overview
7.4 GlaxoSmithKline
7.4.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.4.2 Anti-Obesity Drugs Product Category, Application and Specification
7.4.2.1 Product A
7.4.2.2 Product B
7.4.3 GlaxoSmithKline Anti-Obesity Drugs Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
7.4.4 Main Business/Business Overview
7.5 AstraZeneca
7.5.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.5.2 Anti-Obesity Drugs Product Category, Application and Specification
7.5.2.1 Product A
7.5.2.2 Product B
7.5.3 AstraZeneca Anti-Obesity Drugs Capacity, Production, Revenue, Price and Gross Margin (2015-2018)
7.5.4 Main Business/Business Overview
7.6 Boehringer Ingelheim
7.6.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.6.2 Anti-Obesity Drugs Product Category, Application and Specification
7.6.2.1 Product A
7.6.2.2 Product B
7.6.3 Boehringer Ingelheim Anti-Obesity Drugs Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
7.6.4 Main Business/Business Overview
7.7 Novo Nordisk
7.7.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.7.2 Anti-Obesity Drugs Product Category, Application and Specification
7.7.2.1 Product A
7.7.2.2 Product B
7.7.3 Novo Nordisk Anti-Obesity Drugs Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
7.7.4 Main Business/Business Overview
7.8 Eisai
7.8.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.8.2 Anti-Obesity Drugs Product Category, Application and Specification
7.8.2.1 Product A
7.8.2.2 Product B
7.8.3 Eisai Anti-Obesity Drugs Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
7.8.4 Main Business/Business Overview
7.9 Norgine
7.9.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.9.2 Anti-Obesity Drugs Product Category, Application and Specification
7.9.2.1 Product A
7.9.2.2 Product B
7.9.3 Norgine Anti-Obesity Drugs Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
7.9.4 Main Business/Business Overview
7.8 Arena Pharmaceuticals
7.10.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.10.2 Anti-Obesity Drugs Product Category, Application and Specification
7.10.2.1 Product A
7.10.2.2 Product B
7.10.3 Arena Pharmaceuticals Anti-Obesity Drugs Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
7.10.4 Main Business/Business Overview
7.11 Orexigen Therapeutics
7.12 Vivus
7.13 Alizyme
7.14 Rhythm Pharmaceuticals
7.15 Shionogi
7.16 Zafgan

8 Anti-Obesity Drugs Manufacturing Cost Analysis
8.1 Anti-Obesity Drugs Key Raw Materials Analysis
8.1.1 Key Raw Materials
8.1.2 Price Trend of Key Raw Materials
8.1.3 Key Suppliers of Raw Materials
8.1.4 Market Concentration Rate of Raw Materials
8.2 Proportion of Manufacturing Cost Structure
8.2.1 Raw Materials
8.2.2 Labor Cost
8.2.3 Manufacturing Expenses
8.3 Manufacturing Process Analysis of Anti-Obesity Drugs

9 Industrial Chain, Sourcing Strategy and Downstream Buyers
9.1 Anti-Obesity Drugs Industrial Chain Analysis
9.2 Upstream Raw Materials Sourcing
9.3 Raw Materials Sources of Anti-Obesity Drugs Major Manufacturers in 2017
9.4 Downstream Buyers

10 Marketing Strategy Analysis, Distributors/Traders
10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.1.3 Marketing Channel Development Trend
10.2 Market Positioning
10.2.1 Pricing Strategy
10.2.2 Brand Strategy
10.2.3 Target Client
10.3 Distributors/Traders List

11 Market Effect Factors Analysis
11.1 Technology Progress/Risk
11.1.1 Substitutes Threat
11.1.2 Technology Progress in Related Industry
11.2 Consumer Needs/Customer Preference Change
11.3 Economic/Political Environmental Change

12 Global Anti-Obesity Drugs Market Forecast (2018-2025)
12.1 Global Anti-Obesity Drugs Capacity, Production, Revenue Forecast (2018-2025)
12.1.1 Global Anti-Obesity Drugs Capacity, Production and Growth Rate Forecast (2018-2025)
12.1.2 Global Anti-Obesity Drugs Revenue and Growth Rate Forecast (2018-2025)
12.1.3 Global Anti-Obesity Drugs Price and Trend Forecast (2018-2025)
12.2 Global Anti-Obesity Drugs Production, Consumption , Import and Export Forecast by Region (2018-2025)
12.2.1 North America Anti-Obesity Drugs Production, Revenue, Consumption, Export and Import Forecast (2018-2025)
12.2.2 Europe Anti-Obesity Drugs Production, Revenue, Consumption, Export and Import Forecast (2018-2025)
12.2.3 China Anti-Obesity Drugs Production, Revenue, Consumption, Export and Import Forecast (2018-2025)
12.2.4 Japan Anti-Obesity Drugs Production, Revenue, Consumption, Export and Import Forecast (2018-2025)
12.2.5 Southeast Asia Anti-Obesity Drugs Production, Revenue, Consumption, Export and Import Forecast (2018-2025)
12.2.6 India Anti-Obesity Drugs Production, Revenue, Consumption, Export and Import Forecast (2018-2025)
12.3 Global Anti-Obesity Drugs Production, Revenue and Price Forecast by Type (2018-2025)
12.4 Global Anti-Obesity Drugs Consumption Forecast by Application (2018-2025)

13 Research Findings and Conclusion

14 Appendix
14.1 Methodology/Research Approach
14.1.1 Research Programs/Design
14.1.2 Market Size Estimation
14.1.3 Market Breakdown and Data Triangulation
14.2 Data Source
14.2.1 Secondary Sources
14.2.2 Primary Sources
14.3 Disclaimer


Table of Figures

List of Tables and Figures

Figure Picture of Anti-Obesity Drugs
Figure Global Anti-Obesity Drugs Production (K Units) and CAGR (%) Comparison by Types (Product Category) (2013-2025)
Figure Global Anti-Obesity Drugs Production Market Share by Types (Product Category) in 2017
Figure Product Picture of Prescription Drugs
Table Major Manufacturers of Prescription Drugs
Figure Product Picture of OTC drugs
Table Major Manufacturers of OTC drugs
Figure Global Anti-Obesity Drugs Consumption (K Units) by Applications (2013-2025)
Figure 6-18 Callant Examples
Table Key Downstream Customer in 6-18 Callant
Figure 18-30 Adult Examples
Table Key Downstream Customer in 18-30 Adult
Figure 30-60Middle-Aged Examples
Table Key Downstream Customer in 30-60Middle-Aged
Figure Others Examples
Table Key Downstream Customer in Others
Figure Global Anti-Obesity Drugs Market Size (Million USD), Comparison (K Units) and CAGR (%) by Regions (2013-2025)
Figure North America Anti-Obesity Drugs Revenue (Million USD) and Growth Rate (2013-2025)
Figure Europe Anti-Obesity Drugs Revenue (Million USD) and Growth Rate (2013-2025)
Figure China Anti-Obesity Drugs Revenue (Million USD) and Growth Rate (2013-2025)
Figure Japan Anti-Obesity Drugs Revenue (Million USD) and Growth Rate (2013-2025)
Figure Southeast Asia Anti-Obesity Drugs Revenue (Million USD) and Growth Rate (2013-2025)
Figure India Anti-Obesity Drugs Revenue (Million USD) and Growth Rate (2013-2025)
Figure Global Anti-Obesity Drugs Revenue (Million USD) Status and Outlook (2013-2025)
Figure Global Anti-Obesity Drugs Capacity, Production (K Units) Status and Outlook (2013-2025)
Figure Global Anti-Obesity Drugs Major Players Product Capacity (K Units) (2013-2018)
Table Global Anti-Obesity Drugs Capacity (K Units) of Key Manufacturers (2013-2018)
Table Global Anti-Obesity Drugs Capacity Market Share of Key Manufacturers (2013-2018)
Figure Global Anti-Obesity Drugs Capacity (K Units) of Key Manufacturers in 2017
Figure Global Anti-Obesity Drugs Capacity (K Units) of Key Manufacturers in 2018
Figure Global Anti-Obesity Drugs Major Players Product Production (K Units) (2013-2018)
Table Global Anti-Obesity Drugs Production (K Units) of Key Manufacturers (2013-2018)
Table Global Anti-Obesity Drugs Production Share by Manufacturers (2013-2018)
Figure 2017 Anti-Obesity Drugs Production Share by Manufacturers
Figure 2017 Anti-Obesity Drugs Production Share by Manufacturers
Figure Global Anti-Obesity Drugs Major Players Product Revenue (Million USD) (2013-2018)
Table Global Anti-Obesity Drugs Revenue (Million USD) by Manufacturers (2013-2018)
Table Global Anti-Obesity Drugs Revenue Share by Manufacturers (2013-2018)
Table 2017 Global Anti-Obesity Drugs Revenue Share by Manufacturers
Table 2018 Global Anti-Obesity Drugs Revenue Share by Manufacturers
Table Global Market Anti-Obesity Drugs Average Price (USD/Unit) of Key Manufacturers (2013-2018)
Figure Global Market Anti-Obesity Drugs Average Price (USD/Unit) of Key Manufacturers in 2017
Table Manufacturers Anti-Obesity Drugs Manufacturing Base Distribution and Sales Area
Table Manufacturers Anti-Obesity Drugs Product Category
Figure Anti-Obesity Drugs Market Share of Top 3 Manufacturers
Figure Anti-Obesity Drugs Market Share of Top 5 Manufacturers
Table Global Anti-Obesity Drugs Capacity (K Units) by Region (2013-2018)
Figure Global Anti-Obesity Drugs Capacity Market Share by Region (2013-2018)
Figure Global Anti-Obesity Drugs Capacity Market Share by Region (2013-2018)
Figure 2017 Global Anti-Obesity Drugs Capacity Market Share by Region
Table Global Anti-Obesity Drugs Production by Region (2013-2018)
Figure Global Anti-Obesity Drugs Production (K Units) by Region (2013-2018)
Figure Global Anti-Obesity Drugs Production Market Share by Region (2013-2018)
Figure 2017 Global Anti-Obesity Drugs Production Market Share by Region
Table Global Anti-Obesity Drugs Revenue (Million USD) by Region (2013-2018)
Table Global Anti-Obesity Drugs Revenue Market Share by Region (2013-2018)
Figure Global Anti-Obesity Drugs Revenue Market Share by Region (2013-2018)
Table 2017 Global Anti-Obesity Drugs Revenue Market Share by Region
Figure Global Anti-Obesity Drugs Capacity, Production (K Units) and Growth Rate (2013-2018)
Table Global Anti-Obesity Drugs Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Table North America Anti-Obesity Drugs Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Table Europe Anti-Obesity Drugs Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Table China Anti-Obesity Drugs Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Table Japan Anti-Obesity Drugs Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Table Southeast Asia Anti-Obesity Drugs Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Table India Anti-Obesity Drugs Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Table Global Anti-Obesity Drugs Consumption (K Units) Market by Region (2013-2018)
Table Global Anti-Obesity Drugs Consumption Market Share by Region (2013-2018)
Figure Global Anti-Obesity Drugs Consumption Market Share by Region (2013-2018)
Figure 2017 Global Anti-Obesity Drugs Consumption (K Units) Market Share by Region
Table North America Anti-Obesity Drugs Production, Consumption, Import & Export (K Units) (2013-2018)
Table Europe Anti-Obesity Drugs Production, Consumption, Import & Export (K Units) (2013-2018)
Table China Anti-Obesity Drugs Production, Consumption, Import & Export (K Units) (2013-2018)
Table Japan Anti-Obesity Drugs Production, Consumption, Import & Export (K Units) (2013-2018)
Table Southeast Asia Anti-Obesity Drugs Production, Consumption, Import & Export (K Units) (2013-2018)
Table India Anti-Obesity Drugs Production, Consumption, Import & Export (K Units) (2013-2018)
Table Global Anti-Obesity Drugs Production (K Units) by Type (2013-2018)
Table Global Anti-Obesity Drugs Production Share by Type (2013-2018)
Figure Production Market Share of Anti-Obesity Drugs by Type (2013-2018)
Figure 2017 Production Market Share of Anti-Obesity Drugs by Type
Table Global Anti-Obesity Drugs Revenue (Million USD) by Type (2013-2018)
Table Global Anti-Obesity Drugs Revenue Share by Type (2013-2018)
Figure Production Revenue Share of Anti-Obesity Drugs by Type (2013-2018)
Figure 2017 Revenue Market Share of Anti-Obesity Drugs by Type
Table Global Anti-Obesity Drugs Price (USD/Unit) by Type (2013-2018)
Figure Global Anti-Obesity Drugs Production Growth by Type (2013-2018)
Table Global Anti-Obesity Drugs Consumption (K Units) by Application (2013-2018)
Table Global Anti-Obesity Drugs Consumption Market Share by Application (2013-2018)
Figure Global Anti-Obesity Drugs Consumption Market Share by Applications (2013-2018)
Figure Global Anti-Obesity Drugs Consumption Market Share by Application in 2017
Table Global Anti-Obesity Drugs Consumption Growth Rate by Application (2013-2018)
Figure Global Anti-Obesity Drugs Consumption Growth Rate by Application (2013-2018)
Table Pfizer Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Pfizer Anti-Obesity Drugs Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Pfizer Anti-Obesity Drugs Production Growth Rate (2013-2018)
Figure Pfizer Anti-Obesity Drugs Production Market Share (2013-2018)
Figure Pfizer Anti-Obesity Drugs Revenue Market Share (2013-2018)
Table Merck Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Merck Anti-Obesity Drugs Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Merck Anti-Obesity Drugs Production Growth Rate (2013-2018)
Figure Merck Anti-Obesity Drugs Production Market Share (2013-2018)
Figure Merck Anti-Obesity Drugs Revenue Market Share (2013-2018)
Table F.Hoffmann-La Roche Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table F.Hoffmann-La Roche Anti-Obesity Drugs Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure F.Hoffmann-La Roche Anti-Obesity Drugs Production Growth Rate (2013-2018)
Figure F.Hoffmann-La Roche Anti-Obesity Drugs Production Market Share (2013-2018)
Figure F.Hoffmann-La Roche Anti-Obesity Drugs Revenue Market Share (2013-2018)
Table GlaxoSmithKline Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table GlaxoSmithKline Anti-Obesity Drugs Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure GlaxoSmithKline Anti-Obesity Drugs Production Growth Rate (2013-2018)
Figure GlaxoSmithKline Anti-Obesity Drugs Production Market Share (2013-2018)
Figure GlaxoSmithKline Anti-Obesity Drugs Revenue Market Share (2013-2018)
Table AstraZeneca Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table AstraZeneca Anti-Obesity Drugs Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure AstraZeneca Anti-Obesity Drugs Production Growth Rate (2013-2018)
Figure AstraZeneca Anti-Obesity Drugs Production Market Share (2013-2018)
Figure AstraZeneca Anti-Obesity Drugs Revenue Market Share (2013-2018)
Table Boehringer Ingelheim Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Boehringer Ingelheim Anti-Obesity Drugs Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Boehringer Ingelheim Anti-Obesity Drugs Production Growth Rate (2013-2018)
Figure Boehringer Ingelheim Anti-Obesity Drugs Production Market Share (2013-2018)
Figure Boehringer Ingelheim Anti-Obesity Drugs Revenue Market Share (2013-2018)
Table Novo Nordisk Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Novo Nordisk Anti-Obesity Drugs Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Novo Nordisk Anti-Obesity Drugs Production Growth Rate (2013-2018)
Figure Novo Nordisk Anti-Obesity Drugs Production Market Share (2013-2018)
Figure Novo Nordisk Anti-Obesity Drugs Revenue Market Share (2013-2018)
Table Eisai Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Eisai Anti-Obesity Drugs Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Eisai Anti-Obesity Drugs Production Growth Rate (2013-2018)
Figure Eisai Anti-Obesity Drugs Production Market Share (2013-2018)
Figure Eisai Anti-Obesity Drugs Revenue Market Share (2013-2018)
Table Norgine Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Norgine Anti-Obesity Drugs Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Norgine Anti-Obesity Drugs Production Growth Rate (2013-2018)
Figure Norgine Anti-Obesity Drugs Production Market Share (2013-2018)
Figure Norgine Anti-Obesity Drugs Revenue Market Share (2013-2018)
Table Arena Pharmaceuticals Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Arena Pharmaceuticals Anti-Obesity Drugs Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Arena Pharmaceuticals Anti-Obesity Drugs Production Growth Rate (2013-2018)
Figure Arena Pharmaceuticals Anti-Obesity Drugs Production Market Share (2013-2018)
Figure Arena Pharmaceuticals Anti-Obesity Drugs Revenue Market Share (2013-2018)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Anti-Obesity Drugs
Figure Manufacturing Process Analysis of Anti-Obesity Drugs
Figure Anti-Obesity Drugs Industrial Chain Analysis
Table Raw Materials Sources of Anti-Obesity Drugs Major Manufacturers in 2017
Table Major Buyers of Anti-Obesity Drugs
Table Distributors/Traders List
Figure Global Anti-Obesity Drugs Capacity, Production (K Units) and Growth Rate Forecast (2018-2025)
Figure Global Anti-Obesity Drugs Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure Global Anti-Obesity Drugs Price (Million USD) and Trend Forecast (2018-2025)
Table Global Anti-Obesity Drugs Production (K Units) Forecast by Region (2018-2025)
Figure Global Anti-Obesity Drugs Production Market Share Forecast by Region (2018-2025)
Table Global Anti-Obesity Drugs Consumption (K Units) Forecast by Region (2018-2025)
Figure Global Anti-Obesity Drugs Consumption Market Share Forecast by Region (2018-2025)
Figure North America Anti-Obesity Drugs Production (K Units) and Growth Rate Forecast (2018-2025)
Figure North America Anti-Obesity Drugs Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Table North America Anti-Obesity Drugs Production, Consumption, Export and Import (K Units) Forecast (2018-2025)
Figure Asia-Pacific Anti-Obesity Drugs Production (K Units) and Growth Rate Forecast (2018-2025)
Figure Asia-Pacific Anti-Obesity Drugs Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Table Asia-Pacific Anti-Obesity Drugs Production, Consumption, Export and Import (K Units) Forecast (2018-2025)
Figure Europe Anti-Obesity Drugs Production (K Units) and Growth Rate Forecast (2018-2025)
Figure Europe Anti-Obesity Drugs Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Table Europe Anti-Obesity Drugs Production, Consumption, Export and Import (K Units) Forecast (2018-2025)
Figure Central & South America Anti-Obesity Drugs Production (K Units) and Growth Rate Forecast (2018-2025)
Figure Central & South America Anti-Obesity Drugs Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Table Central & South America Anti-Obesity Drugs Production, Consumption, Export and Import (K Units) Forecast (2018-2025)
Figure Southeast Asia Anti-Obesity Drugs Production (K Units) and Growth Rate Forecast (2018-2025)
Figure Southeast Asia Anti-Obesity Drugs Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Table Southeast Asia Anti-Obesity Drugs Production, Consumption, Export and Import (K Units) Forecast (2018-2025)
Figure India Anti-Obesity Drugs Production (K Units) and Growth Rate Forecast (2018-2025)
Figure India Anti-Obesity Drugs Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Table India Anti-Obesity Drugs Production, Consumption, Export and Import (K Units) Forecast (2018-2025)
Table Global Anti-Obesity Drugs Production (K Units) Forecast by Type (2018-2025)
Figure Global Anti-Obesity Drugs Production (K Units) Forecast by Type (2018-2025)
Table Global Anti-Obesity Drugs Revenue (Million USD) Forecast by Type (2018-2025)
Figure Global Anti-Obesity Drugs Revenue Market Share Forecast by Type (2018-2025)
Table Global Anti-Obesity Drugs Price Forecast by Type (2018-2025)
Table Global Anti-Obesity Drugs Consumption (K Units) Forecast by Application (2018-2025)
Figure Global Anti-Obesity Drugs Consumption (K Units) Forecast by Application (2018-2025)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Source

Request Sample

* mark fields are compulsory